D
Diana Nichols-Vinueza
Researcher at Boston Children's Hospital
Publications - 15
Citations - 341
Diana Nichols-Vinueza is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Functional gastrointestinal disorder & Irritable bowel syndrome. The author has an hindex of 8, co-authored 14 publications receiving 311 citations. Previous affiliations of Diana Nichols-Vinueza include Children's Medical Center of Dallas & University of Valle.
Papers
More filters
Journal ArticleDOI
Prevalence of functional gastrointestinal disorders in Colombian school children.
TL;DR: FGIDs are common in Colombian school children and are more common in females, according to the translated Questionnaire on Pediatric Gastrointestinal Symptoms-Rome III Version.
Journal ArticleDOI
Parental report of abdominal pain and abdominal pain-related functional gastrointestinal disorders from a community survey.
TL;DR: The prevalence ofAP by parental report is lower than the previously published prevalence of AP reported by children, suggesting lack of awareness of children's symptoms may play a role in the low ratio of consultation for AP in symptomatic children.
Journal ArticleDOI
Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
TL;DR: Physicians should be aware of the possibility of new-onset psychotic symptoms and rhabdomyolysis in patients that use SC.
Journal ArticleDOI
A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.
Amaranto Suarez,Martha Piña,Diana Nichols-Vinueza,John Edgar Lopera,Lyda Rengifo,Mauricio Mesa,Marcela Cardenas,Lisa Morrissey,Galo Veintemilla,Martha Vizcaino,Ligia Del Toro,Victor Vicuna,Jorge H. Fernandez,Donna Neuberg,Kristen E. Stevenson,Alejandro Gutierrez,Alejandro Gutierrez +16 more
TL;DR: Treatment‐related mortality and abandonment of therapy are major barriers to successful treatment of childhood acute lymphoblastic leukemia (ALL) in the developing world.
Journal ArticleDOI
Construct validity of the pediatric Rome III criteria.
Miguel Saps,Diana Nichols-Vinueza,Stijn Mintjens,Cenk Pusatcioglu,Carlos Alberto Velasco-Benítez +4 more
TL;DR: Children with a Rome III diagnosis had significantly more gastrointestinal and nongastrointestinal complaints, and greater intensity of symptoms and disability than children without an FGID diagnosis, and the study suggests that the Rome III pediatric criteria have adequate construct validity.